Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics

Zacharias, 1996, Factors predisposing sternotomy complications, Chest, 110, 1173, 10.1378/chest.110.5.1173

Vuorisalo, 1998, Risk features for surgical-site infections in coronary artery bypass surgery, Infect Control Hosp Epidemiol, 19, 240, 10.2307/30142414

Roy, 1998, Surgical-site infections after coronary artery bypass graft surgery, Infect Control Hosp Epidemiol, 19, 229, 10.2307/30142412

L’Ecuyer, 1996, The epidemiology of chest and leg wound infections following cardiothoracic surgery, Clin Infect Dis, 22, 424, 10.1093/clinids/22.3.424

Nagachinta, 1987, Risk factors for surgical wound infection following cardiac surgery, J Infect Dis, 156, 967, 10.1093/infdis/156.6.967

Williams, 1959, Nasal staphylococci and sepsis in hospital patients, Br Med J, ii, 658, 10.1136/bmj.2.5153.658

Weinstein, 1959, The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications, N Engl J Med, 260, 1303, 10.1056/NEJM195906252602601

Kluytmans, 1995, Nasal carriage of staphylococcus aureus as a major risk factor for wound infections after cardiac surgery, J Infect Dis, 171, 216, 10.1093/infdis/171.1.216

Kluytmans, 1998, Reduction of surgical site infections in major surgery by elimination of nasal carriage of staphylococcus aureus, J Hosp Infect, 40, S25, 10.1016/S0195-6701(98)90201-8

Nelson, 1986, The economic implications of infection in cardiac surgery, Ann Thor Surg, 42, 240, 10.1016/S0003-4975(10)62726-9

Reagan, 1991, Elimination of coincident staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment, Ann Internl Med, 114, 101, 10.7326/0003-4819-114-2-101

Ruef, 1996, Sternal wound infection after heart operations in pediatric patients associated with nasal carriage of staphylococcus aureus, J Cardiovasc Surg, 112, 681

Kluytmans, 1996, Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of staphylococcus aureus, Infect Control Hosp Epidemiol, 17, 780, 10.2307/30141170

Casewell, 1998, The nose, J Hosp Infect, 40, S3, 10.1016/S0195-6701(98)90199-2

Hudson, 1994, The efficacy of intranasal mupirocin in the prevention of staphylococcal infections, J Hosp Infect, 27, 81, 10.1016/0195-6701(94)90001-9

Smith, 1999, Emergence of vancomycin resistance in staphylococcus aureus, N Engl J Med, 340, 493, 10.1056/NEJM199902183400701

Perl, 1998, New approaches to reduce staphylococcus aureus nosocomial infection rates, Ann Pharmacother, 32, 7, 10.1177/106002809803200104

Doebbeling, 1993, Elimination of Staphylococcus aureus nasal carriage in health care workers, Clin Infect Dis, 17, 466, 10.1093/clinids/17.3.466

Zerr, 1998, Glucose control lowers the risk of wound infection in diabetics after open heart operations, Ann Thorac Surg, 63, 356, 10.1016/S0003-4975(96)01044-2

American Heart Association. 1996 Stroke and Heart Disease Statistics.

Martin, 1999, A randomized clinical trial of mupirocin in the eradication of staphylococcus aureus nasal carriage in human immunodeficiency virus disease, J Infect Dis, 180, 896, 10.1086/314949

Miller, 1996, Development of mupirocin resistance among methicillin-resistant staphylococcus aureus after widespread use of nasal mupirocin ointment, Infect Control Hosp Epidemiol, 17, 811, 10.2307/30141176

Skellem P, Toy G, Lang S. Staphylococcus aureus highly resistant to mupirocin now common in Auckland. N Z Med J 1998;Mar 13;111(1061):82.

Boyce, 1996, Preventing staphylococcal infections by eradicating nasal carriage of staphylococcus aureus, Infect Control Hosp Epidemiol, 17, 775, 10.2307/30141169

Harbarth, 1999, Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant staphylococcus aureus, Antimicrob Agents Chemother, 43, 1412, 10.1128/AAC.43.6.1412